2023
DOI: 10.1038/s43856-023-00370-1
|View full text |Cite
|
Sign up to set email alerts
|

The future landscape of large language models in medicine

Jan Clusmann,
Fiona R. Kolbinger,
Hannah Sophie Muti
et al.

Abstract: Large language models (LLMs) are artificial intelligence (AI) tools specifically trained to process and generate text. LLMs attracted substantial public attention after OpenAI’s ChatGPT was made publicly available in November 2022. LLMs can often answer questions, summarize, paraphrase and translate text on a level that is nearly indistinguishable from human capabilities. The possibility to actively interact with models like ChatGPT makes LLMs attractive tools in various fields, including medicine. While these… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
101
0
1

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 286 publications
(102 citation statements)
references
References 61 publications
0
101
0
1
Order By: Relevance
“…1 The classification of tumour stages depends on the diameter of the primary tumour (stage I: <2 cm, stage II: >2 cm), metastatic spread into regional lymph nodes (stage III), and distant metastasis (stage IV). 1 The 5-year survival is reported to be 50.6% for local disease, 35.4% for nodal disease, and 13.5% for distant disease. 1 Surgical therapy remains the basis of management for MCC including primary excision and locoregional evaluation by sentinel node biopsy (SNB).…”
Section: Declaration Of Conflicting Interestsmentioning
confidence: 99%
See 4 more Smart Citations
“…1 The classification of tumour stages depends on the diameter of the primary tumour (stage I: <2 cm, stage II: >2 cm), metastatic spread into regional lymph nodes (stage III), and distant metastasis (stage IV). 1 The 5-year survival is reported to be 50.6% for local disease, 35.4% for nodal disease, and 13.5% for distant disease. 1 Surgical therapy remains the basis of management for MCC including primary excision and locoregional evaluation by sentinel node biopsy (SNB).…”
Section: Declaration Of Conflicting Interestsmentioning
confidence: 99%
“…To the Editor, Merkel cell carcinoma (MCC) is a rare neuroendocrine malignancy with a low incidence between 0.3/100000/year and 1.6/100000/year but with high mortality. 1 The classification of tumour stages depends on the diameter of the primary tumour (stage I: <2 cm, stage II: >2 cm), metastatic spread into regional lymph nodes (stage III), and distant metastasis (stage IV). 1 The 5-year survival is reported to be 50.6% for local disease, 35.4% for nodal disease, and 13.5% for distant disease.…”
Section: Declaration Of Conflicting Interestsmentioning
confidence: 99%
See 3 more Smart Citations